Comparative Pharmacology
Head-to-head clinical analysis: FORTICAL versus PARATHAR.
Peer-Reviewed Evidence
Head-to-head clinical analysis: FORTICAL versus PARATHAR.
FORTICAL vs PARATHAR
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Fortical (calcitonin salmon) is a synthetic polypeptide hormone that lowers blood calcium by inhibiting osteoclast-mediated bone resorption and increasing renal excretion of calcium and phosphate.
Recombinant human parathyroid hormone (PTH 1-84) that binds to PTH1 receptor, stimulating osteoblast activity and bone formation, increasing bone mineral density.
50 IU (0.25 mL) subcutaneously once daily, with calcium and vitamin D supplementation.
50-100 mcg subcutaneously once daily.
None Documented
None Documented
Terminal elimination half-life: 43-51 minutes. Rapid clearance; requires twice-daily dosing for sustained calcium-lowering effect.
Terminal half-life: 4-6 hours (prolonged to 10-12 hours in renal impairment; caution in CrCl <30 mL/min).
Renal: 50-70% of absorbed dose excreted unchanged in urine; fecal: 30-50% as unabsorbed drug.
Renal: 70% unchanged, biliary/fecal: 20% as metabolites, 10% as unchanged drug in feces.
Category C
Category C
Osteoporosis Agent
Osteoporosis Agent